Neurosurgery is a method of diagnosing & treating neurological diseases including Alzheimer’s disease, strokes, aneurysms, Parkinson’s disease, degenerative diseases, and also trauma to the spinal cord & brain. Neurosurgery robots help surgeons to perform complex operations with greater flexibility and precision. These robots are frequently preferred in the minimally invasive surgeries (MIS) for better precision. Robotic surgeries provide many advantages including lower risk of surgical site infection, fewer complications in terms of pain and blood loss, quick recovery, and smaller scars. Both mechanical arms and camera arms are extensively used robotic surgical systems. Compared to other types of MIS, the robotic surgery provides improved view and more-precision to the surgeons.
Robotic neurosurgery is a rapidly developing technology due to a number of advantages over traditional neurosurgery for instance faster recovery, shorter hospital stay, better outcomes, and higher accuracy and among others. These surgical robots help in stereotactic procedures & endoscopic manoeuvres. Robotic technology is commonly used to perform stereotactic and endoscopic procedures. Some common neurosurgical applications include telepresence, robotized microscope, and tumour resection.
Referring to study, “Europe Neurosurgical Robotics Market 2020-2027 by Product, Equipment Type, End User and Country: Market Size, Share, Forecast and Strategy” some of the major companies that are presently perating in the Europe neurosurgical robotics market include Stryker Corp. / MAKO, Mazor Robotics Ltd., Simbionix USA Corp., Synaptive Medical, Inc., SONOWAND AS, Zimmer Biomet Holdings, Inc. / Medtech, Siemens Healthineers, Medtronic Inc., DePuy Synthes (Johnson & Johnson), Shenzhen Institutes of Advanced Technology (SIAT), Brainlab AG, Mazor Robotics Ltd and among others. To strengthen their position in the European neurosurgical robot market, major companies are now focusing on adopting several strategies such as recent developments, mergers & acquisitions, joint ventures, product innovations and partnerships.
Aging is associated with a wide range of diseases & disorders. Most of the elderly people suffer from the neurological disorders. Therefore, it is predicted that the increasing aging of the population will drive the European market for neurosurgical surgical robots throughout the forecast period. In addition, existing market participants are adopting a variety of best practices and strategies to develop new manufacturing processes for technologically advanced neurosurgical robots. It is estimated that this will fuel demand for neurosurgical robots for diagnosing various diseases during the forecast period. Apart from this, high price of neurosurgery surgical robots combined with shortage of skilled-professions are estimated to slow the growth of neurosurgery surgical robots market in the upcoming years.
Based on country-wise analysis, the Europe neurosurgical robotics market is segmented as Russia, UK, Italy, Germany, France, Spain and rest of the Europe region. It is projected that Europe neurosurgical robotics market will be reached at rapid pace as a result of rapid progress in the health care industry, rise in minimally invasive surgeries, increase in the purchasing power of hospitals, growth in geriatric population coupled with increase in incidence of neurological disorders during the forecast period. In the future, new technologies will be introduced that will allow robotic systems to analyze the tissue composition by combining images, biomarkers and biomarkers of these tissues to provide particular treatment as well as repair any abnormal tissue damage.
For More Information, click on the link below:-
Ankur Gupta, Head Marketing & Communications